Drug information for DEPO-SUBQ PROVERA 104
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; SUBCUTANEOUS
104MG/0.65ML
Prescription
(Reference Drug)
MEDROXYPROGESTERONE ACETATE
Medroxyprogesterone Acetate
PHARMACIA AND UPJOHN
21583
2009-07-17 Letter
2009-07-16 Label
2007-10-10 Letter
2007-10-10 Label
2007-05-09 Review
2005-11-18 Letter
2005-11-16 Label
2005-05-04 Letter
2004-12-30 Letter
2004-12-30 Label
INJECTABLE; SUSPENSION
0
Prescription
MEDROXYPROGESTERONE ACETATE
Medroxyprogesterone Acetate
PFIZER
21584
2005-12-01 Review
2005-03-30 Letter
2005-03-30 Label
Drug Adverse Effects information for DEPO-SUBQ PROVERA 104
Role code
Indications
Reaction
# Reports
PS
ANTIPHOSPHOLIPID SYNDROME
RASH
2
PS
ANTIPHOSPHOLIPID SYNDROME
SWELLING
2
PS
ANTIPHOSPHOLIPID SYNDROME
URTICARIA
2
PS
CONTRACEPTION
RASH
2
PS
CONTRACEPTION
SWELLING
2
PS
CONTRACEPTION
URTICARIA
2
I
CONTRACEPTION
DRUG INEFFECTIVE
1
I
CONTRACEPTION
DRUG INTERACTION
1
I
CONTRACEPTION
MENSTRUATION DELAYED
1
I
CONTRACEPTION
UNINTENDED PREGNANCY
1
I
UPPER RESPIRATORY TRACT INFECTION
DRUG INEFFECTIVE
1
I
UPPER RESPIRATORY TRACT INFECTION
DRUG INTERACTION
1
I
UPPER RESPIRATORY TRACT INFECTION
MENSTRUATION DELAYED
1
I
UPPER RESPIRATORY TRACT INFECTION
UNINTENDED PREGNANCY
1
Ads by Google